Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1Dermatologic 1Classical hematology 1

Conditions

Neoplasms 4Febrile Neutropenia 4Neutropenia 3Urinary Tract Infections 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1Pneumonia 1Pain 1Migraine Disorders 1Menorrhagia 1Meningitis, Bacterial 1Meningitis 1Leukemia 1Intraabdominal Infections 1Influenza, Human 1Inflammation 1Infections 1Hypokalemia 1Hypertension 1Hyperaldosteronism 1Herpes Simplex 1Hemophilia A 1

Interventions

Vancomycin 2Meropenem 2Ceftazidime 2pegfilgrastim 1ofatumumab 1Teicoplanin 1Surveys and Questionnaires 1Ritonavir 1Quality of Life 1Piperacillin, Tazobactam Drug Combination 1Metformin 1Lenalidomide 1Cloxacillin 1Cilastatin, Imipenem Drug Combination 1Cefepime 1Bevacizumab 1Amikacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fever × Cefepime × Classical hematology × Clear all
NCT04187755 2019-12-06

Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever

Indonesia University

Phase 4 Completed
72 enrolled
Classical hematologyOther hematologic neoplasm

Fever, Leukemia, Neoplasms, Neutropenia, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡